Pleiotropic Effects of PCSK-9 Inhibitors

Proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors are a group of drugs whose main mechanism of action is binding to the PCSK-9 molecule, which reduces the degradation of the low-density lipoprotein receptor (LDL-R) and, hence, increases the uptake of low-density lipoprotein cholester...

Descripción completa

Detalles Bibliográficos
Autores principales: Basiak, Marcin, Kosowski, Michał, Cyrnek, Marcin, Bułdak, Łukasz, Maligłówka, Mateusz, Machnik, Grzegorz, Okopień, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003510/
https://www.ncbi.nlm.nih.gov/pubmed/33808697
http://dx.doi.org/10.3390/ijms22063144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003510/
https://www.ncbi.nlm.nih.gov/pubmed/33808697
http://dx.doi.org/10.3390/ijms22063144

Ejemplares similares